Oskar Hansson

Eli Lilly (United States) — United States

Medicine · Health Sciences

142h-index82.8kcitations1.6kworks22.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(638), Dementia and Cognitive Impairment Research(601), Functional Brain Connectivity Studies(161), Parkinson's Disease Mechanisms and Treatments(144), Advanced Neuroimaging Techniques and Applications(101)

Publications1.6k total

High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia
Neurology·2025· 1 citedOpen Access
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
EMBO Molecular Medicine·2025Open Access
Locus coeruleus‐entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein
Alzheimer s & Dementia·2025· 1 citedOpen Access
Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera
Journal of Nuclear Cardiology·2025Open Access
CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy
Neurobiology of Disease·2025Open Access
The tau biomarker cascade is condensed in Down syndrome compared to sporadic Alzheimer's disease
Brain·2025
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?
Clinical Chemistry·2025· 2 citedOpen Access
Taurine Intake, Plasma Taurine Concentration, and Dementia Risk: Findings From the Malmö Diet and Cancer Study
Journal of Neurochemistry·2025· 1 citedOpen Access
Estimating the time course of biomarker changes in Alzheimer’s disease
Brain·2025Open Access
Plasma p-tau <sub>217</sub> correlates strongly with cerebrospinal fluid Aβ <sub>42</sub> and increases over a ten-year period in amyloid-positive, non-demented very old men
Journal of Alzheimer s Disease·2025Open Access
Biological classification of memory clinic patients
Brain·2025· 2 citedOpen Access
Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer's Disease in an ethnically diverse mixed memory clinic cohort
Journal of the Neurological Sciences·2025Open Access
P-TAU205 IS A BIOMARKER LINKED TO TAU-PET ABNORMALITY: A CROSS-SECTIONAL AND LONGITUDINAL STUDY
2025Open Access
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease
JAMA Neurology·2025· 4 citedOpen Access
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
Brain·2025Open Access
Patient-specific functional brain architecture explains cortical patterns of tau PET in Alzheimer's disease
2025Open Access
How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2025· 1 citedOpen Access
Complementary utility of plasma biomarkers and Aβ‐PET for diagnosis, risk‐stratification, and treatment monitoring in Alzheimer's disease
Alzheimer s & Dementia·2025· 2 citedOpen Access
Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
Alzheimer s & Dementia·2025· 10 citedOpen Access
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study
Acta Neuropathologica·2025· 1 citedOpen Access
page 1 of 82Next →

Frequent Co-authors

Kaj Blennow(31), Henrik Zetterberg(30), Niklas Mattsson(24), Sebastian Palmqvist(23), Erik Stomrud(20), Shorena Janelidze(15), Ruben Smith(11), Olof Strandberg(10), Lennart Minthon(9), Jeffrey L. Dage(9), Shorena Janelidze(8), Ulf Andréasson(8), Gil D. Rabinovici(8), Clifford R. Jack(7), Charlotte E. Teunissen(7), Rik Ossenkoppele(7), Xiyun Chai(5), Nicholas K. Proctor(5), Nicholas J. Ashton(5), Michael Schöll(5)